Polymerase chain reaction (PCR) in vitro

Ended Awarded Last action

Contract number
W911SR23F7008
Awardee
Awarding agency
Obligated
$1,861,866

Award facts

Opportunity
  • W911QY12R0021 Solicitation number
Contract value 84% obligated
$2,208,072.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Millcreek, UT 84107, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 -$43,504
Funding Only Action P00003 · The contractor shall develop a pre-EUA polymerase chain reaction in vitro diagnostic assay panel to address department of defense requirements for non-variola… -$302,702
Change Order P00002 $0
Other Administrative Action P00001 · Orthopox PCR assay $0
Original award $2,208,073

About this award

This is a delivery order contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for Polymerase Chain Reaction (PCR) in vitro products and services, with a ceiling value of $2,208,072.56. The contract has an ultimate completion date of October 31, 2023 and uses a Cost Plus Fixed Fee pricing type.

Biofire Defense LLC is an experienced federal contractor, having been awarded multiple Indefinite Delivery Vehicles (IDVs) and grants from agencies such as the Department of State and National Institutes of Health. The company specializes in manufacturing biological agent identification products and providing advanced diagnostic solutions to federal agencies, with a focus on biological threat detection, infectious disease diagnostics, and public health preparedness. This contract award demonstrates Biofire Defense's continued role as a critical provider of molecular diagnostic technologies to support the government's medical and health readiness initiatives.

Quick answers

Who was awarded contract W911SR23F7008?

W911SR23F7008 was awarded to Biofire Defense LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on February 24, 2023.

How much is contract W911SR23F7008 worth?

The government has obligated $1,861,866 on W911SR23F7008. Its current value, with exercised options, is $2,208,073.

Which agency awarded contract W911SR23F7008?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR23F7008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Is contract W911SR23F7008 an order under another contract?

Yes. W911SR23F7008 is a delivery order under W911QY13D0080, an indefinite delivery contract.

Was contract W911SR23F7008 competed?

The extent of competition for W911SR23F7008 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award